Afaxys Pharma, LLC
13 drugs in NADAC|13 Generic,0 Brand
Afaxys Pharma, LLC lists 13 NDCs in the CMS NADAC file (13 generic, 0 brand), at an average NADAC of $0.61 per unit, with a week-over-week move of -1.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
13
13G / 0B
Avg Price / Unit
$0.6085
$0.09 – $6.33
Avg 7d Change
-0.98%
Across 13 drugs with changes
7d Activity
of 13 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Norgestimate and Ethinyl Estradiol market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Progestin therapeutic class
Review the broader class where Afaxys Pharma, LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Afaxys Pharma, LLC make?
Afaxys Pharma, LLC lists 13 NDCs in the CMS NADAC file — 13 generic and 0 brand products.
What is the average price of Afaxys Pharma, LLC drugs?
The average NADAC across Afaxys Pharma, LLC's portfolio is $0.6085 per unit, ranging from $0.0924 to $6.3306.
What types of drugs does Afaxys Pharma, LLC make?
Afaxys Pharma, LLC makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Progestin (2), Progestin-containing Intrauterine System (1).
Has Afaxys Pharma, LLC had any drug recalls?
No FDA enforcement recalls are matched to Afaxys Pharma, LLC in the openFDA feed.
How has Afaxys Pharma, LLC's pricing changed recently?
Over the past 7 days, 4 Afaxys Pharma, LLC products rose and 9 fell, with a portfolio-wide average change of -1.0%.